• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

BlackRock Health Sciences Opportunities Portfolio

+ Add to Watchlist

BHSRX:US

46.90 USD 0.08 0.17%

As of 09:29:30 ET on 08/22/2014.

Snapshot for BlackRock Health Sciences Opportunities Portfolio (BHSRX)

Year To Date: +15.09% 3-Month: +9.91% 3-Year: - 52-Week Range: 35.80 - 46.99
1-Month: +3.78% 1-Year: +29.39% 5-Year: - Beta vs SPX: 0.95

Mutual Fund Chart for BHSRX

No chart data available.
  • BHSRX:US 46.90
  • 1M
  • 1Y
Interactive BHSRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BHSRX

BlackRock Health Sciences Opportunities Portfolio is an open-end fund incorporated in the USA. The Fund's objective is long-term growth of capital. The Fund normally invests at least 80% of total assets in securities of companies in health sciences and related industries.

Inception Date: 09-12-2011 Telephone: 1-800-441-7762
Managers: THOMAS P CALLAN / H ERIN XIE
Web Site: www.blackrock.com

Fundamentals for BHSRX

NAV (on 2014-08-22) 46.90
Assets (M) (on 2014-08-22) 3,998.08
Fund Leveraged N
Minimum Investment 100.00
Minimum Subsequent Investment 0.00

Dividends for BHSRX

Dividend Type Short Term Cap Gain
Dividend Frequency Irreg
Last Dividend Net (on 2013-12-13) 2.38
Dividend Yield (ttm) 8.60

Fees & Expenses for BHSRX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.72
Redemption Fee 0.00
12b1 Fee 0.50
Expense Ratio 1.54

Top Fund Holdings for BHSRX

Filing Date: 07/31/2014
Name Position Value % of Total
Biogen Idec Inc 392,000 131,080,880 3.442%
Merck & Co Inc 2,118,700 120,215,038 3.157%
Celgene Corp 1,379,138 120,191,877 3.156%
AbbVie Inc 2,241,700 117,330,578 3.081%
Johnson & Johnson 1,081,600 108,257,344 2.843%
Alexion Pharmaceuticals Inc 663,017 105,413,073 2.768%
Covidien PLC 1,151,000 99,573,010 2.615%
UnitedHealth Group Inc 1,185,482 96,083,316 2.523%
Amgen Inc 705,310 89,849,441 2.359%
Actavis plc 399,747 85,649,719 2.249%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil